178 related articles for article (PubMed ID: 36528847)
1. Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes.
Vohra M; Sharma AR; Mallya S; Prabhu NB; Jayaram P; Nagri SK; Umakanth S; Rai PS
J Endocrinol Invest; 2023 Jun; 46(6):1205-1218. PubMed ID: 36528847
[TBL] [Abstract][Full Text] [Related]
2. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
[TBL] [Abstract][Full Text] [Related]
3. The influence of SLC22A3 rs543159 and rs1317652 genetic variants on metformin therapeutic efficacy in newly diagnosed patients with type 2 diabetes mellitus: 25 weeks follow-up study.
Taheri R; Kazerouni F; Mirfakhraei R; Kalbasi S; Shahrokhi SZ; Rahimipour A
Gene; 2022 May; 823():146382. PubMed ID: 35240257
[TBL] [Abstract][Full Text] [Related]
4. A Pharmacometabolomic Approach to Predict Response to Metformin in Early-Phase Type 2 Diabetes Mellitus Patients.
Park JE; Jeong GH; Lee IK; Yoon YR; Liu KH; Gu N; Shin KH
Molecules; 2018 Jun; 23(7):. PubMed ID: 29966242
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.
Raj GM; Mathaiyan J; Wyawahare M; Priyadarshini R
Drug Metab Pers Ther; 2018 Dec; 33(4):175-185. PubMed ID: 30433870
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: A systematic review.
Mofo Mato EP; Guewo-Fokeng M; Essop MF; Owira PMO
Medicine (Baltimore); 2018 Jul; 97(27):e11349. PubMed ID: 29979413
[TBL] [Abstract][Full Text] [Related]
7. No significant association of type 2 diabetes-related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives.
Martono DP; Heerspink HJL; Hak E; Denig P; Wilffert B
Diabetes Obes Metab; 2019 Oct; 21(10):2267-2273. PubMed ID: 31168905
[TBL] [Abstract][Full Text] [Related]
8. Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus.
Nasykhova YA; Barbitoff YA; Tonyan ZN; Danilova MM; Nevzorov IA; Komandresova TM; Mikhailova AA; Vasilieva TV; Glavnova OB; Yarmolinskaya MI; Sluchanko EI; Glotov AS
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893047
[TBL] [Abstract][Full Text] [Related]
9. Differential increments of basal glucagon-like-1 peptide concentration among SLC47A1 rs2289669 genotypes were associated with inter-individual variability in glycaemic response to metformin in Chinese people with newly diagnosed Type 2 diabetes.
Liang H; Xu W; Zhou L; Yang W; Weng J
Diabet Med; 2017 Jul; 34(7):987-992. PubMed ID: 28321905
[TBL] [Abstract][Full Text] [Related]
10. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.
Pérez-Gómez N; Fernández-Ortega MD; Elizari-Roncal M; Santos-Mazo E; la Maza-Pereg L; Calvo S; Alcaraz R; Sanz-Solas A; Vinuesa R; Saiz-Rodríguez M
Pharmacogenomics; 2023 Aug; 24(12):651-663. PubMed ID: 37610884
[TBL] [Abstract][Full Text] [Related]
11. Clinical Study on the Relationship between the SNP rs8192675 (C/C) Site of SLC2A2 Gene and the Hypoglycemic Effect of Metformin in Type 2 Diabetes.
Ye W; Wang Y; Chen F; Zhao Q; Meng X; Chen J; Liu C; Zhou Y
J Healthc Eng; 2022; 2022():3645336. PubMed ID: 35140900
[TBL] [Abstract][Full Text] [Related]
12. The association study between changes in HbA1C with rs2250486 and rs67238751 genetic variants for SLC47A1 in newly diagnosed Iranian patients with type 2 diabetes mellitus: 6 months follow-up study.
Semnani A; Kazerouni F; Kalbasi S; Shahrokhi SZ; Rahimipour A
Endocrinol Diabetes Metab; 2023 May; 6(3):e410. PubMed ID: 36786075
[TBL] [Abstract][Full Text] [Related]
13. A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes.
Tkáč I; Javorský M; Klimčáková L; Židzik J; Gaľa I; Babjaková E; Schroner Z; Štolfová M; Hermanová H; Habalová V
Eur J Clin Pharmacol; 2015 Jan; 71(1):59-63. PubMed ID: 25327507
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the rs3088442 G>A SLC22A3 Gene Polymorphism and the Role of microRNA 147 in Groups of Adult Pakistani Populations With Type 2 Diabetes in Response to Metformin.
Moeez S; Riaz S; Masood N; Kanwal N; Arif MA; Niazi R; Khalid S
Can J Diabetes; 2019 Mar; 43(2):128-135.e3. PubMed ID: 30297296
[TBL] [Abstract][Full Text] [Related]
15. A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.
Clement Y; Singh S; Motilal S; Maharaj R; Nunez-Smith M
Ethn Dis; 2020; 30(Suppl 1):211-216. PubMed ID: 32269463
[TBL] [Abstract][Full Text] [Related]
16. Exploring metformin monotherapy response in Type-2 diabetes: Computational insights through clinical, genomic, and proteomic markers using machine learning algorithms.
Villikudathil AT; Mc Guigan DH; English A
Comput Biol Med; 2024 Mar; 171():108106. PubMed ID: 38368755
[TBL] [Abstract][Full Text] [Related]
17. Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes.
Phani NM; Vohra M; Kakar A; Adhikari P; Nagri SK; D'Souza SC; Umakanth S; Satyamoorthy K; Rai PS
Pharmacogenomics; 2018 Jul; 19(11):905-911. PubMed ID: 29914345
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients.
Zaharenko L; Kalnina I; Geldnere K; Konrade I; Grinberga S; Židzik J; Javorský M; Lejnieks A; Nikitina-Zake L; Fridmanis D; Peculis R; Radovica-Spalvina I; Hartmane D; Pugovics O; Tkáč I; Klimčáková L; Pīrāgs V; Klovins J
Eur J Endocrinol; 2016 Dec; 175(6):531-540. PubMed ID: 27609360
[TBL] [Abstract][Full Text] [Related]
19. A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 diabetes mellitus patients.
Borges JL; Bilezikian JP; Jones-Leone AR; Acusta AP; Ambery PD; Nino AJ; Grosse M; Fitzpatrick LA; Cobitz AR
Diabetes Obes Metab; 2011 Nov; 13(11):1036-46. PubMed ID: 21682834
[TBL] [Abstract][Full Text] [Related]
20. Clinical Determinants of Diabetes Progression in Multiethnic Asians with Type 2 Diabetes - A 3-Year Prospective Cohort Study.
Liu S; Liu JJ; Gurung RL; Chan C; Yeo D; Ang K; Tang WE; Tavintharan S; Sum CF; Lim SC
Ann Acad Med Singap; 2019 Jul; 48(7):217-223. PubMed ID: 31495867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
